Legal Opinion

In Re Pharm. Industry Average Wholesale Price Lit.

Court of Appeals for the First Circuit

Decided September 23, 2009No. 08-1056PublishedCited by 94 opinions

1Opinion of the Court

582 F.3d 156 (2009)

In re PHARMACEUTICAL INDUSTRY AVERAGE WHOLESALE PRICE LITIGATION.

Blue Cross Blue Shield of Massachusetts, et al., Plaintiffs, Appellees,

v.

AstraZeneca Pharmaceuticals LP, Defendant, Appellant.

No. 08-1056.

United States Court of Appeals, First Circuit.

Heard November 4, 2008.

Decided September 23, 2009.

Mark E. Haddad, with whom Nitin Reddy, Carter G. Phillips, Sidley Austin LLP, D. Scott Wise, Michael S. Flynn, Kimberley D. Harris, Davis Polk & Wardwell, Donald R. Ware, Sarah Cooleybeck and Foley Hoag LLP, were on brief for appellant.

Steve W. Berman, with whom Sean R. Matt,…

2Cases cited87 opinions

  1. Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
  2. Anderson v. City of Bessemer CitySupreme Court of the United States · 1985
  3. Amchem Products, Inc. v. WindsorSupreme Court of the United States · 1997
  4. General Electric Co. v. JoinerSupreme Court of the United States · 1997
  5. United States v. Ilario M.A. ZanninoCourt of Appeals for the First Circuit · 1990

82 more not listed; retrieve them via the Exa API.

3Cited by94 opinions

  1. Omnicare, Inc. v. Unitedhealth Group, Inc.Court of Appeals for the Seventh Circuit · 2011
  2. Vince Mullins v. Direct Digital, LLCCourt of Appeals for the Seventh Circuit · 2015
  3. Katz v. Pershing, LLCCourt of Appeals for the First Circuit · 2012
  4. Antilles Cement Corp. v. Cemex De Puerto Rico, Inc.Court of Appeals for the First Circuit · 2012
  5. Curtis Lumber Co., Inc. v. Louisiana Pacific Corp.Court of Appeals for the Eighth Circuit · 2010

89 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API